Areeba Sadiq, MD
Urology · New York, NYNPI 1619354164
Payments from drug & device makers
Across 43 payments — averaging $649.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$27K
- Bayer$253
- Teleflex LLC$190
- Procept Biorobotics Corporation$169
- Palette Life Sciences, Inc.$157
- Coloplast$103
- plus $52 from 2 others
What the payments were for
- Grants$25,00090%
- Food & beverage$2,90710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 32 | $26,983 |
| Bayer | 3 | $253 |
| Teleflex LLC | 1 | $190 |
| Procept Biorobotics Corporation | 2 | $169 |
| Palette Life Sciences, Inc. | 2 | $157 |
| Coloplast | 1 | $103 |
| Shionogi Inc | 1 | $29 |
| Cook Medical LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL KIDNEY STONE DISEASE$25,756
- Nubeqa$213
- UroLift$190
- AquaBeam Robotic System$149
- LithoVue$127
- LITHOCLAST$119
- Xofigo$110
- Coloplast TFL Drive$103
How this compares
$27,907 in reported general payments places this provider in the 85th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Citrate ErPotassium Citrate | 168 | $27,923 |
| Cefpodoxime Proxetil | 176 | $7,189 |
| Oxybutynin Chloride ErOxybutynin Chloride | 80 | $2,018 |
| Klor-Con-EfPotassium Bicarbonate/Cit Ac | 11 | $1,182 |
| Tamsulosin Hcl | 66 | $864 |
| Chlorthalidone | 15 | $505 |
| Cephalexin | 133 | $266 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 35 | $237 |
| Ciprofloxacin Hcl | 53 | $214 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 27 | $210 |
| Levofloxacin | 25 | $165 |
| Fluconazole | 21 | $119 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $99 |
| Finasteride | 11 | $87 |
| Allopurinol | 15 | $80 |
Paid to pharmacies, not to this prescriber.
Other urology in New York
- Guarionex DecastroNew York$5.7M
- James McKiernanNew York$4.1M
- William HuangNew York$3.9M
- Ashutosh TewariNew York$2.5M
- Bilal ChughtaiNew York$1.5M
- Nils Peter WiklundNew York$1M
- Herbert LeporNew York$823K
- Christopher AndersonNew York$785K
- Katie MurrayNew York$776K
- John SfakianosNew York$726K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.